Summary
During the last 4 years, we have studied the adriamycin-DNA complex originally developed by Trouet and co-workers (1972). This paper summarizes the results of our pharmacologic and clinical studies.
The complex is taken up by cells through an adsorptive pinocytosis, with DNA as the binding molecule. Excess DNA prevents uptake of the drug. Administration of the drug as the complex results in much higher serum concentration and a reduced urinary excretion. The complex is well tolerated, but side effects are probably of the same order as those seen with the free drug. An exception may be the heart. The acute toxicity is not seen when infusing the complex. Our experience with 20 children who have received more than 500 mg/m2 indicates that the chronic cardiac toxicity may be reduced, too.
Spectacular, but anecdotal, results have been observed in a variety of solid tumors. Of 16 children with acute myelogenous leukemia, 14 went into a complete remission on a protocol of cytosine arabinoside in combination with the complex. Three of these children are now off therapy, with the longest observation period being 4 years and 4 months.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ansari B. M., Thompson, E. N., Whittaker, J. A.: A comparative study of acute myeloblastic leukaemia in children and adults. Br. J. Haematol. 31, 269 (1975)
Arena E., d'Allesandro, N., Dusonchet, L., Gebbia, N., Gerbasi, F., Ralazzoandrino, M., Rainieri, A., Rausa, L., Tubaro, E.: Analysis of pharmacokinetic ccharacteiristics, pharmacological and chemotherapeutic activity of 14-hydroxydaunomycin (adriamycin), a new drug endowed with an anti-tumour activity. Arzneim.-Forsch. 8, 1258 (1971)
Atassi, G., Duarte-Karim, M., Tagnon, H. J.: Comparison of adriamycin with DNA-adriamycin complex in chemotherapy of experimental tumours and metastasis. Eur. J. Cancer 11, 309 (1975)
Bachur, N. R., Leon Moor, A., Bernstein J. G., Liu, A.: Tissue distribution and disposition of daunomycin (NSC-82151) in mice. Fluorometric and isotopic methods. Cancer Chemother. Rep. [Part 1] 54, 2 (1970)
Bachur, N. R., Hildebrand, R. C., Jaenke, R. S.: Adriamycin and daunorubicin disposition in the rabbit. J. Pharmacol. Exp. Ther. 191, 331 (1974)
Benjamin, R. S., Riggs, C. E., Bachur, N. R.: Pharmacokinetics and metabolism of adriamycin in man. Clin. Pharmacol. Ther. 14, 592 (1974)
Blum, R. H., Carter, S. K.: Adriamycin. A new anticancer drug with significant clinical activity. Ann. Intern. Med. 80, 259 (1974)
Calendi, E., DiMarco, A., Reggiani, M., Scarpinato, B., Valentini, L.: On physicochemical interactions between daunomycin and nucleic acids. Biochim. Biophys. Acta 103, 25 (1965)
Easty, G. C.: The uptake of fluorescent labelled proteins by normal and tumour tissues in vivo. Br. J. Cancer 18, 368 (1964)
Evans, D. I. K., Jones, P. H. M., Morley, C. J.: Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone and mercaptopurine or thioguanine, Cancer 36, 1547 (1975)
Gale, R. P., Cline, M. J.: High remission-induction rate in acute myeloid leukemia. Lancet 1977 I, 497
Gey, G. O.: Some aspects of the constitution and behaviour of normal and malignant cells maintained in continuous culture. Harvey Lect. 50, 154 (1956)
Ghose, T., Nairn, R. C., Fothergill, J. E.: Uptake of proteins by malignant cells. Nature 196, 1108 (1962)
Goldin, A., Johnson, R. K.: Antitumour effect of adriamycin in comparison with related drugs, and in combination chemotherapy. In: Adriamycin review. Staquet, M. et al. (eds.), p. 37, Ghent: European Press Medikon 1975
Hoff, D. D. von, Rozencweig, M., Layard, M., Slavik M., Muggia, F. M.: Daunomycin induced cardiotoxicity in children and adults. A review of 110 cases. Am. J. Med. 62, 200 (1977)
Kummen, M., Lie, K. K., Lie, S. O.: A pharmacokinetic evaluation of free and DNA-complexed adriamycin: A preliminary study in children with malignant disease. Acta Pharmacol. Toxicol. (Kbh.) 42, 212 (1978)
Langslet, A., Øye, I., Lie, S. O.: Decreased cardiac toxicity of adriamycin and daunorubicin when bound to DNA. Acta Pharmacol. Toxicol. (Kbh.) 35, 379 (1974)
Lefrak, E. A., Pitha, J., Rosenheim, S., Gottlieb, J. A.: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32, 203 (1973)
Lie, K. K., Lie, S. O.: Studies on cellular uptakes of free and complexed adriamycin. Proc. 9th Congr. The Nordic Society for Cell Biololy. Bierring, F. (ed.), p. 121. Odense, Denmark: Odense University Press 1976
Lie, S. O., Lie, K. K., Uptake of free and DNA-complexed adriamycin. In. Methodological surveys in biochemistry. Reid, E. (ed.), Vol. 6, p. 397. New York: John Wiley and Sons 1977
Lie, S. O., Lie, K. K., Langslet, A.: Experiences with DNA-adriamycin complex in malignant disorder of childhood. In: Adriamycin review. Staquet, M. et al. (eds.), p. 226. Ghent: European Press Medikon 1975
Lie, S. O., Lie, K. K., Glomstein, A.: Adriamycin-DNA complex: A new principle in the therapy of childhood malignancies. Pediatr. Res. 11, 1019 (1977)
Marco, A. di, Arcamone, F.: DNA complexing antibiotics: Daunomycin, adriamycin and their derivates. Arzneim.-Forsch. 25, 368 (1975)
Preisler, H. D., Bjørnsson, S., Henderson, E. S.: Adriamycin-cytosine arabinoside therapy for adult acute leucemia. Cancer Treat. Rep. 61, 391 (1975)
Propper, R., Camitta, B., Jaffe, N., Traggis, D., Sallan, S.: Increased adriamycin (A) cardiotoxicity in leucemic children. Pediatr. Res. 9, 391 (1975)
Sokal, G., Trouet, A., Michaux, J., Cornu, G.: DNA-daunorubin complex: Preliminary trials in human, leucemia. Eur. J Cancer 9, 391, (1973)
Trouet, A., Deprez-de Campeneere, D., Duve, C. de: Chemotherapy through lysosomes with DNA-daunorubicin complex. Nature [New Biol.] 239, 110 (1972)
Trouet, A., Depzer-de Campeneere, D., Smedt-Malengreaux, M. de, Atassi, G.: Experimental leucemia chemotherapy with a ‘lysosomotropic’ adriamycin-DNA complex. Eur. J. Cancer 10, 405 (1974)
Trouet, A., Deprez-de Campeneere, D., Zeneberg, A., Hullhoven, R.: Lysosomotropic cancer chemotherapy with adriamycin-DNA. In: Adriamycin review. Staquet, M. et al. (eds.) p. 62. Ghent: European Press Medikon 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lie, S.O., Lie, K.K. & Glomstein, A. Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease. Cancer Chemother. Pharmacol. 2, 61–66 (1979). https://doi.org/10.1007/BF00253107
Issue Date:
DOI: https://doi.org/10.1007/BF00253107